Institutional investors purchased a net $630.1 thousand shares of PCRX during the quarter ended September 2013 and now own 103.83% of the total shares outstanding. This majority interest is a greater percentage than is typical for companies in the Pharmaceuticals: Other industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
FIDELITY MANAGEMENT & RESEARCH C... Bought 787.1 Thousand shares of Pacira Pharmaceuticals In...